Biopsy Devices Market Outlook - 2026
The global biopsy devices market size was valued at $2,728 million in 2018 and is expected to reach $4,310 million by 2026, registering a CAGR of 5.9% during the forecast period.
Biopsy is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of a disease, generally cancerous and inflammatory conditions. It is generally performed by surgeons, radiologists, and interventional cardiologists. Biopsies can be performed on any organ using specific biopsy devices as a confirmatory test for cancer and celiac diseases. The usage of each biopsy device varies according to the type of organ under consideration. Conventional biopsy devices can be complemented with advanced imaging technologies, such as MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others, to perform biopsy with accuracy and minimal invasiveness. These integrated procedures are used to perform biopsies on body organs such as the lungs, liver, and kidneys.
Significant increase in incidence of cancer, such as breast, prostate, and lung, and rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound–guided biopsies fuel the adoption of biopsy devices. Moreover, rise in awareness on diagnosis of chronic diseases fosters the demand for integrated biopsy technologies such as stereotactic-guided biopsy. However, high cost of biopsy devices and limited availability of skilled professionals in low income countries hinder the growth of the market.
Biopsy Devices Market Segmentation
The biopsy devices market is segmented on the basis of product, application, imaging technology, end user, and region. Based on product, the market is divided into needle-based biopsy instruments, biopsy forceps, localization wires, and other products. Based on application, the market is classified into breast biopsy, gastrointestinal (GI) biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gynecological biopsy, and others. Based on imaging technology, the market is divided into MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, CT scan, and others. Based on end user, the market is categorized into diagnostic and imaging centers, hospitals, and others. Based on region, the biopsy devices market size is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product segment review
Needle Based Biopsy Devices is projected as one of the most lucrative segments.
Based on product, the biopsy devices market is segmented into needle-based biopsy instruments, biopsy forceps, localization wires, and other products. The needle-based biopsy instruments acquired the largest biopsy devices market share in 2018. Furthermore, this segment is also expected to grow with fastest rate during the forecast period owing to increase in number of breast cancer, gastrointestinal tract diseases, and soft tissue sarcomas. Aspiration biopsy needles are non–invasive and provide efficient sample collection as compared to core biopsy devices, which require an incision. Furthermore, core biopsy devices are higher in cost as compared to vacuum-assisted biopsy devices and aspiration biopsy needles.
Application Segment review
According to application, the breast biopsy in the application segment generated the highest revenue in 2018 and is expected to maintain its dominance throughout the forecast period. This is attributed to increase in number of breast cancer patients that was witnessed over the years across the globe and is expected to maintain this trend in the future. Presently, breast cancer can be identified efficiently using advanced biopsy devices with higher efficiency in less time. In addition, increase in public awareness for disease screening, and technological advancement in biopsy devices has driven the demand for the use of biopsy devices worldwide.
By Imaging Technology
CT scan segment is projected as one of the most lucrative segments.
North America occupied the largest share of the market in 2018 and is expected to maintain its dominance during the forecast period owing to large availability of trained medical professionals, availability of well-developed infrastructure facilities, and presence of majority of key players. However, Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to its high population base, surge in disposable income, and rise in patient awareness toward disease screening. In addition, increase in the geriatric population that is highly susceptible to cancer is the key contributor for the market growth in the region.
The major companies profiled in this report include Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc.
Asia-Pacific region would exhibit the highest CAGR of 7.1% during 2019-2026.
Key Benefits for Biopsy Devices Market:
- The study provides an in-depth analysis of the global biopsy devices market along with the current trends and future estimations to elucidate the imminent investment pockets.
- Comprehensive analysis of the factors that drive and restrict the biopsy devices market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2018 to 2026 is provided to enable the stakeholders to capitalize on the prevailing biopsy devices market opportunities.
- Extensive analysis of the key segments of the industry helps in understanding the application and products of biopsy devices used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Biopsy Devices Market Segments:
- Needle-Based Biopsy Instruments
- Core Biopsy Devices
- Aspiration Biopsy Needles
- Vacuum-Assisted Biopsy Devices
- Biopsy Forceps
- Localization Wires
- Other Products
- Breast biopsy
- Gastroenterology biopsy
- Prostate biopsy
- Liver biopsy
- Lung biopsy
- Kidney biopsy
- Gynecological biopsy
By Imaging Technology
- MRI-guided biopsy
- Stereotactic-guided biopsy
- Ultrasound-guided biopsy
- CT scan
By End User
- Diagnostic & Imaging Centers
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
Biopsy Devices Market Report Highlights
By IMAGING TECHNOLOGY
By END USERS
Key Market Players
Boston Scientific Corporation, Hologic, Inc., B Braun Melsungen AG, Fujifilm Holdings Corp., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Cardinal Health, Inc., Argon Medical Devices, Inc., Medtronic Plc., Becton Dickinson and Company (C. R. Bard, Inc.)
Biopsy devices are used to examine disease by removal of tissue from the affected area or organs through biopsy procedures while conducting diagnostic tests. While imaging techniques such as CT–scans or X–rays are also used in detecting abnormalities in certain body organs, they are not capable of distinguishing between affected and unaffected cells, especially in complicated cases of cancer. Therefore, biopsy is the only confirmatory procedure to diagnose cancer. There are various biopsy products available for different body parts and the type of product used depends on patient’s situation.
The adoption of biopsy devices is expected to witness significant growth, owing to rise in incidence of chronic diseases such as cancer. In addition, these biopsy devices offer several advantages such as minimal invasiveness, less pain, less bleeding, low chances of infection and other complications along with short hospital stay. Moreover, increase in incidence of cancer, surge in awareness about biopsy procedures, and heavy investment by leading companies to promote their products fuel the growth of the biopsy devices market.
Vacuum-assisted core breast biopsies are the most popularly used breast biopsy procedure, as these procedures allow multiple and large volume sampling of tissues with minimal invasion. These biopsies can be performed in outpatient settings and does not require stitching. Thus, biopsy devices are expected to dominate the market in future, owing to high market capitalization and technical advancements. Conversely, stiff competition from alternative cancer diagnostic tests poses a restrain to the market. Whereas, the development of advanced biopsy devices by key manufacturers is expected open new avenues for the expansion of the biopsy devices market.